Partnering and business development is integral to our strategy of building a leading pharmaceutical company. We forge creative partnerships with other innovative companies that advance our business in the field of endocrinology.
Diurnal has major competencies in the development of innovative medicines for the treatment of hormone disorders, and is focused on building a strong product portfolio within this field.
Diurnal will consider out-licensing marketing and development rights to successful projects once key clinical proof-of-principle milestones have been achieved.
Diurnal is also interested in in-licensing commercial-stage products within Europe that are promoted to adult and paediatric endocrinologists.